Pyxis Oncology Inc
NASDAQ:PYXS
Pyxis Oncology Inc
NASDAQ:PYXS
Price:
1.52
USD
2.7%
Market Closed
Market Cap:
$94.6m
Income Statement
Earnings Waterfall
Pyxis Oncology Inc
Pyxis Oncology Inc
Income Statement
Pyxis Oncology Inc
Pyxis Oncology Inc
Currency: USD
| Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||||||
| Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
16
N/A
|
16
N/A
|
16
N/A
|
16
N/A
|
0
N/A
|
3
N/A
|
|
| Gross Profit | ||||||||||||||||||
| Cost of Revenue |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
|
| Gross Profit |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
16
N/A
|
16
N/A
|
16
N/A
|
16
N/A
|
0
N/A
|
0
N/A
|
|
| Operating Income | ||||||||||||||||||
| Operating Expenses |
(49)
|
(58)
|
(70)
|
(65)
|
(85)
|
(102)
|
(123)
|
(113)
|
(105)
|
(102)
|
(82)
|
(83)
|
(84)
|
(83)
|
(84)
|
(107)
|
(109)
|
|
| Selling, General & Administrative |
(8)
|
(11)
|
(19)
|
(27)
|
(33)
|
(38)
|
(37)
|
(35)
|
(33)
|
(35)
|
(32)
|
(32)
|
(31)
|
(26)
|
(25)
|
(23)
|
(22)
|
|
| Research & Development |
(42)
|
(47)
|
(51)
|
(38)
|
(52)
|
(64)
|
(86)
|
(78)
|
(72)
|
(68)
|
(48)
|
(51)
|
(53)
|
(56)
|
(57)
|
(63)
|
(66)
|
|
| Depreciation & Amortization |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(2)
|
0
|
0
|
0
|
(2)
|
0
|
0
|
|
| Other Operating Expenses |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(21)
|
(21)
|
|
| Operating Income |
(49)
N/A
|
(58)
-17%
|
(70)
-20%
|
(65)
+6%
|
(85)
-30%
|
(102)
-20%
|
(123)
-21%
|
(113)
+8%
|
(105)
+7%
|
(102)
+3%
|
(82)
+20%
|
(67)
+19%
|
(69)
-3%
|
(67)
+2%
|
(68)
-2%
|
(107)
-56%
|
(106)
+0%
|
|
| Pre-Tax Income | ||||||||||||||||||
| Interest Income Expense |
(3)
|
(6)
|
(6)
|
(5)
|
(3)
|
0
|
3
|
4
|
4
|
4
|
2
|
1
|
1
|
1
|
1
|
1
|
0
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(21)
|
0
|
0
|
|
| Total Other Income |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
2
|
5
|
7
|
8
|
9
|
9
|
9
|
9
|
8
|
|
| Pre-Tax Income |
(53)
N/A
|
(64)
-21%
|
(76)
-19%
|
(71)
+7%
|
(88)
-25%
|
(101)
-15%
|
(121)
-19%
|
(109)
+10%
|
(99)
+9%
|
(94)
+5%
|
(74)
+22%
|
(58)
+22%
|
(59)
-2%
|
(57)
+3%
|
(79)
-39%
|
(97)
-23%
|
(98)
-1%
|
|
| Net Income | ||||||||||||||||||
| Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
0
|
2
|
|
| Income from Continuing Operations |
(53)
|
(64)
|
(76)
|
(71)
|
(88)
|
(101)
|
(121)
|
(109)
|
(99)
|
(94)
|
(74)
|
(58)
|
(59)
|
(57)
|
(77)
|
(95)
|
(96)
|
|
| Net Income (Common) |
(53)
N/A
|
(64)
-21%
|
(76)
-19%
|
(71)
+7%
|
(88)
-25%
|
(101)
-15%
|
(121)
-19%
|
(109)
+10%
|
(99)
+9%
|
(94)
+5%
|
(74)
+22%
|
(58)
+22%
|
(59)
-2%
|
(57)
+3%
|
(77)
-35%
|
(95)
-23%
|
(96)
-1%
|
|
| EPS (Diluted) |
-1.61
N/A
|
-1.94
-20%
|
-2.36
-22%
|
-2.2
+7%
|
-2.71
-23%
|
-3.11
-15%
|
-3.65
-17%
|
-3.07
+16%
|
-2.57
+16%
|
-2.28
+11%
|
-1.85
+19%
|
-1.12
+39%
|
-0.97
+13%
|
-0.94
+3%
|
-1.32
-40%
|
-1.56
-18%
|
-1.57
-1%
|
|
Switch to:
Switch to:
See Also
Discover More
